![](http://cdn.gdn.ng/wp-content/uploads/2024/06/Open-drug-market-1024x640.jpg)
Prevalence of substandard drugs in open markets sparks fresh concerns
Despite concerted efforts by various drug regulatory agencies to monitor drug distribution, the prevalence of fake and substandard drugs in the nation's open drug markets has continued to threaten the nation's health